Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

The impact of obesity, age, and gender on plasmatic levels of selected glycoprotein biomarkers and miRNA-499 in OSA patients

T. Kostlivy, M. Pesta, J. Windrichova, P. Skopek, P. Klail, A. Skalova, B. Gal, R. Kucera, K. Plickova, V. Simanek, D. Slouka

. 2024 ; 22 (2) : 81-88. [pub] 20240614

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24011946

Grantová podpora
00669806 Ministry of Health, Czech Republic - Czech Republic
CZ.02.1.01/0.0/0.0/16013/0001674 Ministry of Health, Czech Republic - Czech Republic
02.1.01/0.0/0.0/16013/0001674 Ministry of Health, Czech Republic - Czech Republic
LM2018125 Ministry of Health, Czech Republic - Czech Republic

BACKGROUND: The current obstructive sleep apnea (OSA) diagnostic uses polysomnography or limited polygraphy and requires specialized personnel and technical equipment. Glycoprotein biomarkers and microRNAs are being explored as a possible new method for screening. We aimed to evaluate whether certain biomarkers and microRNA, previously identified as related to OSA, could be influenced by factors such as gender, age, and obesity level in patients with OSA. METHODS: In this retrospective analytical study, patients with moderate to severe OSA (n = 130) were compared with the control group. Serum levels of selected biomarkers and microRNA were taken from both groups. The group of OSA patients was then stratified by gender, obesity level, and age to see the possible influence of those variables on biomarker levels. RESULTS: Levels of all studied biomarkers - C-reactive protein (CRP), high-sensitivity troponin I (hsTnI), pentraxin-3 (PTX-3), and microRNA-499 were significantly higher in patients with OSA compared to the control group. In the OSA group only hsTnI showed a statistically significant relationship with gender. Levels of CRP and hsTnI showed a significant dependence on the level of obesity. Dependency on age was proven for hsTnI. CRP, PTX-3, and microRNA-499 did not have any statistically significant relationship with age. CONCLUSION: We found that serum levels of pentraxin-3 and microRNA-499 in patients with moderate to severe obstructive sleep apnoea are independent of gender, obesity, and age. CRP was affected by the level of obesity and hsTnI was influenced by all 3 variables. We consider these findings important for further research of OSA biomarkers.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24011946
003      
CZ-PrNML
005      
20250507141029.0
007      
ta
008      
240711s2024 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.32725/jab.2024.011 $2 doi
035    __
$a (PubMed)38912863
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Kostlivý, Tomáš $u Charles University, University Hospital in Pilsen, Faculty of Medicine in Pilsen, Department of Otorhinolaryngology, Pilsen, Czech Republic $7 xx0231494
245    14
$a The impact of obesity, age, and gender on plasmatic levels of selected glycoprotein biomarkers and miRNA-499 in OSA patients / $c T. Kostlivy, M. Pesta, J. Windrichova, P. Skopek, P. Klail, A. Skalova, B. Gal, R. Kucera, K. Plickova, V. Simanek, D. Slouka
520    9_
$a BACKGROUND: The current obstructive sleep apnea (OSA) diagnostic uses polysomnography or limited polygraphy and requires specialized personnel and technical equipment. Glycoprotein biomarkers and microRNAs are being explored as a possible new method for screening. We aimed to evaluate whether certain biomarkers and microRNA, previously identified as related to OSA, could be influenced by factors such as gender, age, and obesity level in patients with OSA. METHODS: In this retrospective analytical study, patients with moderate to severe OSA (n = 130) were compared with the control group. Serum levels of selected biomarkers and microRNA were taken from both groups. The group of OSA patients was then stratified by gender, obesity level, and age to see the possible influence of those variables on biomarker levels. RESULTS: Levels of all studied biomarkers - C-reactive protein (CRP), high-sensitivity troponin I (hsTnI), pentraxin-3 (PTX-3), and microRNA-499 were significantly higher in patients with OSA compared to the control group. In the OSA group only hsTnI showed a statistically significant relationship with gender. Levels of CRP and hsTnI showed a significant dependence on the level of obesity. Dependency on age was proven for hsTnI. CRP, PTX-3, and microRNA-499 did not have any statistically significant relationship with age. CONCLUSION: We found that serum levels of pentraxin-3 and microRNA-499 in patients with moderate to severe obstructive sleep apnoea are independent of gender, obesity, and age. CRP was affected by the level of obesity and hsTnI was influenced by all 3 variables. We consider these findings important for further research of OSA biomarkers.
650    _2
$a lidé $7 D006801
650    12
$a obstrukční spánková apnoe $x krev $x genetika $7 D020181
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé středního věku $7 D008875
650    12
$a biologické markery $x krev $7 D015415
650    12
$a mikro RNA $x krev $7 D035683
650    12
$a obezita $x krev $x genetika $7 D009765
650    12
$a C-reaktivní protein $x analýza $x metabolismus $7 D002097
650    _2
$a dospělí $7 D000328
650    _2
$a věkové faktory $7 D000367
650    _2
$a sexuální faktory $7 D012737
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a glykoproteiny $x krev $x genetika $7 D006023
650    _2
$a senioři $7 D000368
650    _2
$a sérový amyloidový protein $x metabolismus $x analýza $x genetika $7 D000683
650    _2
$a troponin I $x krev $7 D019210
655    _2
$a časopisecké články $7 D016428
700    1_
$a Pešta, Martin, $d 1976- $u Charles University, Faculty of Medicine in Pilsen, Department of Biology, Pilsen, Czech Republic $7 xx0073915
700    1_
$a Windrichová, Jindra $u Charles University, University Hospital in Pilsen, Faculty of Medicine in Pilsen, Department of Immunochemistry Diagnostics, Pilsen, Czech Republic $7 xx0209887
700    1_
$a Škopek, Petr $u Charles University, University Hospital in Pilsen, Faculty of Medicine in Pilsen, Department of Otorhinolaryngology, Pilsen, Czech Republic $7 xx0248415
700    1_
$a Klail, Pavel, $d 1995- $u Charles University, University Hospital in Pilsen, Faculty of Medicine in Pilsen, Department of Otorhinolaryngology, Pilsen, Czech Republic $7 xx0328572
700    1_
$a Skálová, Alena, $d 1954- $u Charles University, University Hospital in Pilsen, Faculty of Medicine in Pilsen, Department of Pathology, Pilsen, Czech Republic $7 xx0026898
700    1_
$a Gál, Břetislav, $d 1970- $u Masaryk University, Faculty of Medicine, Department of Otorhinolaryngology and Head and Neck Surgery, Brno, Czech Republic $7 xx0123187
700    1_
$a Kučera, Radek $u Charles University, Faculty of Medicine in Pilsen, Department of Pharmacology and Toxicology, Pilsen, Czech Republic $7 jo2016919265
700    1_
$a Plicková, Krista $u Charles University, University Hospital in Pilsen, Faculty of Medicine in Pilsen, Department of Pneumology and Phthisiology, Pilsen, Czech Republic $7 _AN113361
700    1_
$a Šimánek, Václav, $d 1970- $u Charles University, University Hospital in Pilsen, Faculty of Medicine in Pilsen, Department of Otorhinolaryngology, Pilsen, Czech Republic $7 xx0105947
700    1_
$a Slouka, David, $d 1970- $u Charles University, University Hospital in Pilsen, Faculty of Medicine in Pilsen, Department of Otorhinolaryngology, Pilsen, Czech Republic $7 xx0139295
773    0_
$w MED00012667 $t Journal of applied biomedicine $x 1214-0287 $g Roč. 22, č. 2 (2024), s. 81-88
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38912863 $y Pubmed
910    __
$a ABA008 $b B 2301 $c 1249 $y p $z 0
990    __
$a 20240711 $b ABA008
991    __
$a 20250507141027 $b ABA008
999    __
$a ok $b bmc $g 2316456 $s 1223798
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 22 $c 2 $d 81-88 $e 20240614 $i 1214-0287 $m Journal of applied biomedicine $n J Appl Biomed $x MED00012667
GRA    __
$a 00669806 $p Ministry of Health, Czech Republic $2 Czech Republic
GRA    __
$a CZ.02.1.01/0.0/0.0/16013/0001674 $p Ministry of Health, Czech Republic $2 Czech Republic
GRA    __
$a 02.1.01/0.0/0.0/16013/0001674 $p Ministry of Health, Czech Republic $2 Czech Republic
GRA    __
$a LM2018125 $p Ministry of Health, Czech Republic $2 Czech Republic
LZP    __
$b NLK124 $a Pubmed-20240711

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...